Article
Identification of PDE5A:E90K: a polymorphism in the canine phosphodiesterase 5A gene affecting basal cGMP concentrations of healthy dogs.
Journal of veterinary internal medicine - 1 Jan 2000
Stern J A, Reina-Doreste Y, Chdid L, Meurs K M
Abstract excerpt
BACKGROUND: Cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase (PDE5A) is the target of phosphodiesterase inhibitors such as sildenafil. Polymorphisms in the PDE5A gene that may predict response to therapy with sildenafil and nitric oxide, be linked to disease progression, and aid in risk assessment have been identified in human beings. Identification of polymorphisms in PDE5A could affect the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
